IP vs VIR
International Paper (IP) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported VIR revenue for 2024-12-31 was $74.2M. Net income was -$522.0M. Revenue was down 13.9% from 2023-12-31 to 2024-12-31. VIR currently screens at market cap $1.45B.
IP currently screens at market cap $26.62B and trailing P/E 43.1. VIR currently screens at market cap $1.45B.
Not investment advice. Open the IP and VIR stock pages for the full models.
Not investment advice.